TherapeuticsMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.48	5.06	4.33	38.07	64.91
Cash & Short-Term Investments	7.48	5.06	4.33	38.07	64.91
Cash Growth	47.91%	16.92%	-88.63%	-41.35%	-19.36%
Other Receivables	3.53	3.56	3.09	-	-
Total Trade Receivables	3.53	3.56	3.09	-	-
Other Current Assets	3.44	3.64	4.38	17.28	54.56
Total Current Assets	14.45	12.26	11.8	55.35	119.47
Net Property, Plant & Equipment	5.29	6.1	6.87	7.66	9.06
Other Intangible Assets	3.76	4.32	6.1	6.94	7.14
Other Long-Term Assets	14.16	16.14	18.54	20.51	33.8
Total Assets	37.66	38.82	43.31	90.46	169.47
Accounts Payable	0.38	0.26	0.03	2.16	3.37
Accrued Expenses	1.74	2.13	3.13	18.85	13.34
Current Portion of Long-Term Debt	-	-	-	-	188.27
Other Current Liabilities	2.67	2.78	3.69	25.83	47.91
Total Current Liabilities	4.79	5.17	6.85	46.84	252.89
Long-Term Leases	5.12	5.54	6.53	7.37	8.06
Other Long-Term Liabilities	0.87	0.74	0.64	1.11	2.14
Total Long-Term Liabilities	6	6.29	7.17	8.48	10.2
Total Liabilities	10.78	11.45	14.02	55.32	263.09
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	979.26	979.18	978.92	974.5	957.73
Retained Earnings	-952.39	-951.82	-949.64	-939.36	-1,051
Shareholders' Equity	26.88	27.37	29.29	35.14	-93.62
Total Liabilities & Equity	37.66	38.82	43.31	90.46	169.47
Total Debt	5.12	5.54	6.53	7.37	196.33
Net Cash (Debt)	2.36	-0.48	-2.21	30.7	-131.43
Net Cash Per Share	0.20	-0.04	-0.21	3.28	-16.51
Book Value	26.88	27.37	29.29	35.14	-93.62
Book Value Per Share	2.32	2.37	2.80	3.75	-11.76
Tangible Book Value	23.12	23.05	23.19	28.2	-100.77
Tangible Book Value Per Share	2.00	2.00	2.22	3.01	-12.66

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q